Circio logoCircio logo

  • About
      • About Circio
      • CEO Statement
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
  • circRNA
      • Circio AB
      • circVec platform
  • Clinical programs
      • KRAS program
      • Publications
  • Partnering
  • Investors
      • Press releases
      • Events
      • Financial calendar
      • Rights Issue Q1 2026
      • Prospectus
      • Reports
      • Presentations
      • Share facts
      • Largest shareholders
      • Dividend policy
      • Analyst coverage
      • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Articles of Association
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Contact
  • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    • About
      • About Circio
      • CEO Statement
      • Our pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Press releases
      • Events
      • Financial calendar
      • Rights Issue Q1 2026
      • Reports
      • Presentations
      • Prospectus
      • Share information
        • Share and trading information
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Articles of Association
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    • All press releases
    2026
    • 2025
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    All subjects
    • Corporate news
    • Other
    All languages
    • English
    • Norwegian
    January 23, 2026
    Press release - Regulatory

    Circio Holding ASA – Last day of trading in subscription rights in the rights issue

    January 22, 2026
    Press release - Non-regulatory

    Analyst Group publishes initiation report on Circio

    January 21, 2026
    Press release - Regulatory

    Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders

    January 16, 2026
    Press release - Regulatory

    Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders

    January 15, 2026
    Press release - Regulatory

    Circio Holding ASA – Receipt of subscription rights in the rights issue by primary insiders and their close associates

    January 15, 2026
    Press release - Regulatory

    Circio Holding ASA – Commencement of the subscription period for the rights issue

    January 13, 2026
    Press release - Regulatory

    Circio Holding ASA – Approval and publication of prospectus for the rights issue

    January 13, 2026
    Press release - Regulatory

    Circio Holding ASA – Ex. subscription rights today

    January 12, 2026
    Press release - Regulatory

    Circio Holding ASA – Minutes from the extraordinary general meeting 2026 and approval of Rights Issue

    January 12, 2026
    Press release - Regulatory

    Circio invites to live webcast on 15 January 2026 to provide information about the upcoming rights issue

    January 12, 2026
    Press release - Regulatory

    Circio Holding ASA – Extraordinary general meeting held, all agenda items approved

    January 9, 2026
    Press release - Regulatory

    Circio Holding ASA – Updated key information relating to the rights issue

    January 7, 2026
    Press release - Non-regulatory

    Circio and The University of Texas Medical Branch jointly announce collaboration to evaluate circVec for the treatment of infectious diseases

    IR contact
    Dr Erik Digman Wiklund
    Dr Erik Digman Wiklund
    CEO
    erik.wiklund@circio.com
    (+47) 41 33 35 36
    Dr Lubor Gaal
    Dr Lubor Gaal
    CFO & Head of BD
    lubor.gaal@circio.com
    (+34) 683 343 811
    Circio logo

    Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines.

    • About
    • circRNA
    • Clinical programs
    • Partnering
    • Investors
    • Media
    • Contacts

    CONTACT

    Circio Holding ASA
    Email: contact@circio.com

    • Cookies
    • Privacy policy
    • STAY CONNECTED